About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Oxycodone
- Procedure number
- PSUSA/00002254/202204
- Regulatory outcome
- Variation
Documents
Oxycodone : List of nationally authorised medicinal products - PSUSA/00002254/202204
English (EN) (422.58 KB - PDF)
Oxycodone : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002254/202204
English (EN) (201.56 KB - PDF)
български (BG) (244.3 KB - PDF)
español (ES) (215.77 KB - PDF)
čeština (CS) (319.26 KB - PDF)
dansk (DA) (453.58 KB - PDF)
Deutsch (DE) (240.36 KB - PDF)
eesti keel (ET) (211.51 KB - PDF)
ελληνικά (EL) (408.57 KB - PDF)
français (FR) (211.48 KB - PDF)
hrvatski (HR) (301.92 KB - PDF)
íslenska (IS) (243.84 KB - PDF)
italiano (IT) (239.21 KB - PDF)
latviešu valoda (LV) (218.19 KB - PDF)
lietuvių kalba (LT) (231.03 KB - PDF)
magyar (HU) (222.39 KB - PDF)
Malti (MT) (242.37 KB - PDF)
Nederlands (NL) (222.42 KB - PDF)
norsk (NO) (239.88 KB - PDF)
polski (PL) (309.59 KB - PDF)
português (PT) (211.12 KB - PDF)
română (RO) (217.72 KB - PDF)
slovenčina (SK) (422.29 KB - PDF)
slovenščina (SL) (288.7 KB - PDF)
Suomi (FI) (181.09 KB - PDF)
svenska (SV) (255.84 KB - PDF)